Sinequan 10mg/ml Concentrate 120ml

Manufacturer PFIZER U.S. Active Ingredient Doxepin Oral Concentrate(DOKS e pin) Pronunciation DOKS-e-pin
WARNING: Drugs like this one have raised the chance of suicidal thoughts or actions in children and young adults. The risk may be greater in people who have had these thoughts or actions in the past. All people who take this drug need to be watched closely. Call the doctor right away if signs like depression, nervousness, restlessness, grouchiness, panic attacks, or changes in mood or actions are new or worse. Call the doctor right away if any thoughts or actions of suicide occur.This drug is not approved for use in children. Talk with the doctor. @ COMMON USES: It is used to treat depression.It is used to treat anxiety.It may be given to you for other reasons. Talk with the doctor.
đŸˇī¸
Drug Class
Antidepressant, Anxiolytic, Hypnotic
đŸ§Ŧ
Pharmacologic Class
Tricyclic Antidepressant (TCA), Histamine H1 Antagonist
🤰
Pregnancy Category
Category C
✅
FDA Approved
Mar 1969
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Doxepin is a medication used to treat depression, anxiety, and sometimes insomnia. It works by affecting certain natural chemicals in the brain that help regulate mood and sleep. It can make you feel sleepy, especially when you first start taking it.
📋

How to Use This Medicine

Taking Your Medication Correctly

To get the most benefit from your medication, it's essential to follow your doctor's instructions carefully. Read all the information provided with your medication and follow the instructions closely. If you're taking your medication once a day, take it at bedtime.

Continue taking your medication as directed by your doctor or healthcare provider, even if you start to feel well. It's crucial to measure liquid doses accurately using the measuring device that comes with your medication. To take your dose, mix it with 1/2 cup (4 ounces/120 mL) of water, milk, or fruit juice, and drink it immediately. Do not store the mixture for future use, and avoid mixing it with carbonated drinks or grape juice.

Storing and Disposing of Your Medication

To maintain the effectiveness and safety of your medication, store it at room temperature, protected from light, and in a dry place. Avoid storing it in a bathroom. Keep all medications in a safe location, out of the reach of children and pets. When disposing of unused or expired medication, do not flush it down the toilet or pour it down the drain unless instructed to do so by your pharmacist. Instead, check with your pharmacist for guidance on the best disposal method, and consider participating in a drug take-back program in your area.

What to Do If You Miss a Dose

If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses at the same time or take extra doses to make up for the missed one.
💡

Lifestyle & Tips

  • Avoid alcohol and other sedating medications, as they can increase drowsiness and other side effects.
  • Do not drive or operate heavy machinery until you know how this medication affects you.
  • Avoid excessive sun exposure and use sunscreen, as doxepin can increase sensitivity to sunlight.
  • Maintain good oral hygiene due to potential dry mouth.
  • Stay hydrated to help with dry mouth and constipation.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: Depression/Anxiety: 75 mg/day, Insomnia: 6 mg/day
Dose Range: 3 - 300 mg

Condition-Specific Dosing:

Depression and Anxiety: Initial: 25-75 mg/day in a single dose at bedtime or in divided doses. Maintenance: 25-150 mg/day. Max: 300 mg/day.
Insomnia (Silenor): 3 mg or 6 mg once daily within 30 minutes of bedtime. Max: 6 mg/day.
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established for depression/anxiety. Limited off-label use for insomnia (e.g., 0.25-0.5 mg/kg/day, max 25 mg/day) or chronic pain. Use with extreme caution due to Black Box Warning for suicidality.
Adolescent: Not established for depression/anxiety. Limited off-label use for insomnia or chronic pain. Use with extreme caution due to Black Box Warning for suicidality.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No specific adjustment recommended, monitor for adverse effects.
Moderate: No specific adjustment recommended, monitor for adverse effects.
Severe: Use with caution; consider lower doses and monitor for adverse effects due to potential accumulation of parent drug and active metabolite. Doxepin is primarily metabolized by the liver.
Dialysis: Not significantly dialyzable. Use with caution, monitor for adverse effects.

Hepatic Impairment:

Mild: Use with caution; consider lower doses and monitor for adverse effects.
Moderate: Significant dose reduction (e.g., 50-75%) may be necessary. Monitor plasma levels if available and clinical response/adverse effects closely.
Severe: Contraindicated or not recommended due to extensive hepatic metabolism and risk of accumulation and toxicity.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Doxepin is a tricyclic antidepressant (TCA) that primarily inhibits the reuptake of norepinephrine (NE) and serotonin (5-HT) at the presynaptic neuronal membrane, thereby increasing the concentration of these neurotransmitters in the synaptic cleft. It also possesses significant antagonistic activity at histamine H1, alpha-1 adrenergic, muscarinic cholinergic, and 5-HT2 receptors, which contribute to its sedative, anticholinergic, and hypotensive effects.
📊

Pharmacokinetics

Absorption:

Bioavailability: 20-45% (highly variable due to first-pass metabolism)
Tmax: 2-4 hours (doxepin), 6-8 hours (desmethyldoxepin)
FoodEffect: Food may delay absorption but does not significantly affect the extent of absorption.

Distribution:

Vd: 9-33 L/kg
ProteinBinding: Approximately 80-85%
CnssPenetration: Yes

Elimination:

HalfLife: Doxepin: 8-24 hours; Desmethyldoxepin: 28-51 hours
Clearance: Not readily available, highly variable due to extensive metabolism
ExcretionRoute: Renal (primarily as metabolites)
Unchanged: < 3% (doxepin), < 6% (desmethyldoxepin)
âąī¸

Pharmacodynamics

OnsetOfAction: Sedation/Hypnotic: 30-60 minutes; Antidepressant/Anxiolytic: 2-4 weeks (full effect)
PeakEffect: Sedation/Hypnotic: 1-2 hours; Antidepressant/Anxiolytic: 4-6 weeks
DurationOfAction: Sedation/Hypnotic: 6-8 hours; Antidepressant/Anxiolytic: 24 hours (due to long half-life of active metabolite)

Safety & Warnings

âš ī¸

BLACK BOX WARNING

Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of Major Depressive Disorder (MDD) and other psychiatric disorders. Anyone considering the use of doxepin or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond 24 years of age; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber.
âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Attention Immediately

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical help right away:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of high or low blood pressure, including:
+ Severe headache
+ Dizziness
+ Passing out
+ Changes in eyesight
Fast heartbeat
Difficulty urinating
Feeling extremely nervous or excitable
Fever, chills, or sore throat
Unexplained bruising or bleeding
Feeling very tired or weak
Yellowing of the skin or eyes (jaundice)
Ringing in the ears (tinnitus)
Changes in sex interest
Enlarged breasts or nipple discharge
Swelling of the testicles

Important Warning for Asthma Patients

If you have asthma, use this medication with caution. Worsening of asthma has been reported in people taking this medication. If your asthma symptoms worsen while taking this medication, contact your doctor right away.

Other Possible Side Effects

Like all medications, this drug can cause side effects. Many people experience no side effects or only mild ones. However, if you notice any of the following side effects or if they bother you or do not go away, contact your doctor or seek medical help:

Feeling dizzy, sleepy, tired, or weak
Constipation
Diarrhea
Stomach pain
Upset stomach
Vomiting
Decreased appetite
Dry mouth
Changes in taste
Mouth irritation or mouth sores
Weight gain
Excessive sweating
Flushing
Hair loss
Headache

Reporting Side Effects

This list is not exhaustive, and you may experience other side effects not mentioned here. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Worsening depression or thoughts of self-harm/suicide, especially at the beginning of treatment or with dose changes.
  • New or worsening anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (restlessness), hypomania, or mania.
  • Severe dizziness or fainting (orthostatic hypotension).
  • Fast or irregular heartbeat.
  • Difficulty urinating or severe constipation.
  • Blurred vision or eye pain.
  • Confusion or hallucinations.
  • Muscle stiffness, fever, or sweating (signs of serotonin syndrome or neuroleptic malignant syndrome, though rare).
  • Unexplained fever, sore throat, or other signs of infection (may indicate blood problems).
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances. Describe the allergic reaction you experienced, including any symptoms.
Certain health conditions, such as:
+ Difficulty urinating
+ Glaucoma
Current or recent use of specific medications, including:
+ Linezolid or methylene blue
+ Certain antidepressants or Parkinson's disease medications taken within the last 14 days, such as:
- Isocarboxazid
- Phenelzine
- Tranylcypromine
- Selegiline
- Rasagiline (note: taking these medications with this drug can lead to very high blood pressure)
Use of other medications that can cause drowsiness, as combining them with this medication may increase the risk of excessive sleepiness. If you are unsure, consult your doctor or pharmacist.
* Breastfeeding status: do not breastfeed while taking this medication.

This list is not exhaustive, and it is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health conditions with your doctor and pharmacist. They will help determine if it is safe to take this medication with your other medications and health conditions. Never start, stop, or change the dose of any medication without consulting your doctor.
âš ī¸

Precautions & Cautions

Important Information About Your Medication

It is crucial that you inform all of your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.

Caution with Daily Activities
Until you understand how this medication affects you, avoid driving and engaging in other activities that require your full attention.

Full Effects and Stopping the Medication
Please note that it may take several weeks to experience the full effects of this medication. Do not stop taking this medication abruptly without consulting your doctor, as this may increase your risk of side effects. If you need to stop taking this medication, your doctor will guide you on how to gradually discontinue it.

Interactions with Other Substances
Avoid consuming alcohol while taking this medication. Before using marijuana, other forms of cannabis, or prescription and over-the-counter drugs that may cause drowsiness, discuss the potential risks with your doctor.

Eye Problems
Some individuals may be at a higher risk of developing eye problems while taking this medication. Your doctor may recommend an eye exam to assess your risk. If you experience eye pain, changes in vision, or swelling and redness around the eye, contact your doctor immediately.

Sun Sensitivity
This medication may increase your susceptibility to sunburn. Exercise caution when spending time outdoors, and inform your doctor if you experience excessive sunburn.

Blood Sugar Monitoring
If you have diabetes, it is essential to closely monitor your blood sugar levels. Be aware of signs of high or low blood sugar, such as:
- Breath that smells like fruit
- Dizziness
- Fast breathing
- Fast heartbeat
- Feeling confused or sleepy
- Feeling weak
- Flushing
- Headache
- Unusual thirst or hunger
- Frequent urination
- Shaking or sweating
Inform your doctor if you experience any of these symptoms.

Special Considerations for Older Adults
If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects.

Fertility and Pregnancy
Some medications can affect fertility, potentially impacting your ability to have children. If you have concerns, discuss them with your doctor.

Pregnancy and Breastfeeding
If you are pregnant or plan to become pregnant, consult your doctor to weigh the benefits and risks of taking this medication. Taking this medication during the third trimester of pregnancy may pose health risks to the newborn, so it is essential to discuss this with your doctor.
🆘

Overdose Information

Overdose Symptoms:

  • Severe drowsiness or coma
  • Confusion, agitation, hallucinations
  • Severe dry mouth, blurred vision, dilated pupils
  • Fast, irregular, or pounding heartbeat (tachycardia, arrhythmias)
  • Low blood pressure (hypotension)
  • Urinary retention
  • Seizures
  • Respiratory depression
  • Hypothermia

What to Do:

Seek immediate medical attention. Call 911 or Poison Control at 1-800-222-1222. Treatment is supportive and symptomatic, including gastric lavage, activated charcoal, and monitoring of cardiac function (ECG) and vital signs. Physostigmine may be used for severe anticholinergic toxicity, but with caution due to risk of cardiac effects.

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • Monoamine Oxidase Inhibitors (MAOIs) (e.g., phenelzine, tranylcypromine, selegiline, linezolid, methylene blue) - risk of serotonin syndrome, hyperpyretic crises, convulsions, and death. Allow at least 14 days between discontinuing MAOI and starting doxepin, and vice versa.
  • Cisapride (risk of QT prolongation and arrhythmias)
  • Patients with narrow-angle glaucoma or urinary retention (due to anticholinergic effects)
🔴

Major Interactions

  • CNS Depressants (e.g., alcohol, benzodiazepines, opioids, sedatives, hypnotics, antihistamines) - additive CNS depression, respiratory depression, profound sedation, coma.
  • Anticholinergics (e.g., atropine, benztropine, diphenhydramine, oxybutynin) - additive anticholinergic effects (e.g., severe constipation, urinary retention, blurred vision, delirium).
  • Sympathomimetics (e.g., epinephrine, norepinephrine, phenylephrine) - enhanced pressor response, risk of arrhythmias and hypertension.
  • CYP2D6 Inhibitors (e.g., fluoxetine, paroxetine, quinidine, bupropion) - increased plasma concentrations of doxepin and desmethyldoxepin, leading to increased risk of adverse effects.
  • Thyroid Hormones - increased risk of cardiac arrhythmias and toxicity.
  • Antihypertensives (e.g., guanethidine, clonidine, reserpine) - may antagonize the antihypertensive effects; orthostatic hypotension may be exacerbated.
  • QT-prolonging drugs (e.g., antiarrhythmics, antipsychotics, macrolide antibiotics, fluoroquinolones) - increased risk of QT prolongation and torsades de pointes.
🟡

Moderate Interactions

  • Cimetidine - inhibits doxepin metabolism, leading to increased plasma levels.
  • Oral Anticoagulants (e.g., warfarin) - may alter anticoagulant effects, monitor INR.
  • Barbiturates - may decrease doxepin plasma levels due to enzyme induction.
  • Tobacco Smoking - may decrease doxepin plasma levels due to enzyme induction (CYP1A2).
đŸŸĸ

Minor Interactions

  • Not readily categorized as minor due to the broad interaction profile of TCAs; most interactions are clinically significant.

Monitoring

đŸ”Ŧ

Baseline Monitoring

Electrocardiogram (ECG)

Rationale: To assess for pre-existing cardiac conduction abnormalities (e.g., prolonged QT interval, bundle branch block) as TCAs can cause dose-related increases in PR, QRS, and QT intervals and risk of arrhythmias.

Timing: Prior to initiation, especially in patients with cardiac disease or risk factors.

Liver Function Tests (LFTs)

Rationale: Doxepin is extensively metabolized by the liver; to assess baseline hepatic function.

Timing: Prior to initiation.

Renal Function (BUN, Creatinine)

Rationale: To assess baseline renal function, as metabolites are renally excreted.

Timing: Prior to initiation.

Complete Blood Count (CBC) with differential

Rationale: Rare reports of blood dyscrasias (e.g., agranulocytosis, thrombocytopenia).

Timing: Prior to initiation.

Intraocular Pressure (IOP)

Rationale: In patients with a history of narrow-angle glaucoma, due to anticholinergic effects.

Timing: Prior to initiation.

📊

Routine Monitoring

Mental Status and Behavioral Changes (especially suicidality)

Frequency: Weekly during initial therapy (first 4-6 weeks) and with dose changes, then periodically.

Target: Improvement in target symptoms without emergence of new or worsening suicidal thoughts/behaviors, agitation, or mania.

Action Threshold: Immediate clinical evaluation and intervention if new or worsening suicidality, agitation, or manic symptoms occur.

Vital Signs (Blood Pressure, Heart Rate)

Frequency: Periodically, especially during dose titration.

Target: Within normal limits; monitor for orthostatic hypotension and tachycardia.

Action Threshold: Significant orthostatic drop (>20 mmHg systolic, >10 mmHg diastolic) or persistent tachycardia.

Anticholinergic Side Effects (dry mouth, blurred vision, constipation, urinary retention)

Frequency: Regularly, especially in elderly patients.

Target: Tolerable levels.

Action Threshold: Severe or intolerable symptoms requiring intervention or dose adjustment.

Sedation/Drowsiness

Frequency: Regularly.

Target: Tolerable levels, especially if impacting daily activities.

Action Threshold: Excessive sedation impacting safety (e.g., driving) or quality of life.

Therapeutic Drug Monitoring (TDM) - Doxepin and Desmethyldoxepin plasma levels

Frequency: Not routinely recommended for all patients, but may be useful in cases of non-response, suspected toxicity, or significant drug interactions.

Target: Doxepin + Desmethyldoxepin: 100-250 ng/mL (for depression/anxiety)

Action Threshold: Levels outside therapeutic range, correlating with clinical response or toxicity.

đŸ‘ī¸

Symptom Monitoring

  • Worsening depression
  • Suicidal thoughts or behavior
  • Unusual changes in behavior (e.g., agitation, irritability, anxiety, panic attacks, insomnia, aggressiveness, impulsivity, akathisia, hypomania, mania)
  • Cardiac symptoms (e.g., palpitations, dizziness, syncope)
  • Severe constipation or urinary retention
  • Blurred vision or eye pain
  • Confusion or delirium (especially in elderly)
  • Seizures
  • Fever, sore throat, or other signs of infection (suggesting blood dyscrasias)

Special Patient Groups

🤰

Pregnancy

Doxepin is Pregnancy Category C. Use during pregnancy should only be considered if the potential benefit justifies the potential risk to the fetus. Neonates exposed to TCAs in the third trimester have developed withdrawal symptoms (e.g., respiratory distress, feeding difficulties, tremor, hypertonia, seizures).

Trimester-Specific Risks:

First Trimester: Limited human data, but generally not associated with major malformations. Animal studies show some adverse effects at high doses.
Second Trimester: Potential for fetal exposure and effects on developing nervous system.
Third Trimester: Risk of neonatal withdrawal symptoms (e.g., respiratory distress, feeding difficulties, irritability, tremor, hypertonia, seizures) and persistent pulmonary hypertension of the newborn (PPHN).
🤱

Lactation

Doxepin and its active metabolite, desmethyldoxepin, are excreted into breast milk. The American Academy of Pediatrics considers doxepin to be a drug for which the effect on the nursing infant is unknown but may be of concern. Use with caution; monitor infant for sedation, poor feeding, and weight gain. Lower doses may pose less risk.

Infant Risk: L3 (Moderate risk) - Potential for sedation, poor feeding, and other anticholinergic effects in the infant. Consider alternative agents or monitor infant closely.
đŸ‘ļ

Pediatric Use

Not approved for depression or anxiety in pediatric patients. Black Box Warning for increased risk of suicidality in children, adolescents, and young adults. Use for insomnia is off-label and generally reserved for specific cases at very low doses, with careful risk-benefit assessment.

👴

Geriatric Use

Use with extreme caution due to increased sensitivity to anticholinergic effects (e.g., confusion, delirium, urinary retention, constipation), orthostatic hypotension, and sedation. Elderly patients are more prone to falls. Doxepin is on the Beers Criteria list as a potentially inappropriate medication in older adults due to its strong anticholinergic properties and risk of orthostatic hypotension. Start with lower doses and titrate slowly.

Clinical Information

💎

Clinical Pearls

  • Doxepin is a potent H1 antagonist, making it highly sedating. This property is leveraged for its use in insomnia at very low doses (3-6 mg).
  • The oral concentrate form (10 mg/ml) allows for flexible and precise dosing, especially for low-dose insomnia treatment or careful titration in sensitive patients.
  • Due to its anticholinergic and alpha-1 adrenergic blocking effects, doxepin can cause significant dry mouth, constipation, urinary retention, blurred vision, and orthostatic hypotension.
  • Cardiac conduction abnormalities (e.g., QT prolongation, QRS widening) are a concern, especially at higher doses or in patients with pre-existing cardiac disease; baseline ECG is recommended.
  • Withdrawal symptoms (e.g., nausea, headache, malaise, flu-like symptoms, sleep disturbance, irritability) can occur upon abrupt discontinuation, especially after prolonged use. Taper slowly.
  • Therapeutic drug monitoring (TDM) may be useful in cases of non-response, suspected toxicity, or significant drug interactions, aiming for combined doxepin and desmethyldoxepin levels of 100-250 ng/mL for antidepressant effects.
🔄

Alternative Therapies

  • For Depression/Anxiety: SSRIs (e.g., fluoxetine, sertraline, escitalopram), SNRIs (e.g., venlafaxine, duloxetine), other TCAs (e.g., amitriptyline, imipramine, nortriptyline), atypical antidepressants (e.g., bupropion, mirtazapine).
  • For Insomnia: Non-benzodiazepine hypnotics (e.g., zolpidem, eszopiclone, zaleplon), benzodiazepines (e.g., temazepam, lorazepam), melatonin receptor agonists (e.g., ramelteon), antihistamines (e.g., diphenhydramine), trazodone, cognitive behavioral therapy for insomnia (CBT-I).
💰

Cost & Coverage

Average Cost: Varies widely, typically $50-$200 per 120ml of 10mg/ml concentrate
Generic Available: Yes
Insurance Coverage: Tier 1 or Tier 2 (generic), Tier 3 or higher (brand)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor promptly. To ensure safe use, never share your medication with others or take someone else's medication. This medication is accompanied by a Medication Guide, which provides crucial information for patients. Please read this guide carefully and review it again whenever you receive a refill of this medication. If you have any questions or concerns about this medication, consult your doctor, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When reporting the incident, be prepared to provide details about the medication taken, the quantity, and the time it occurred.